News Detail
New Delhi, 11 Sept 2024: The Foreign Direct Investment (FDI) equity inflow into the pharmaceutical sector has reported multifold growth during the first quarter of the current fiscal year, after registering a 48 per cent decline in the fiscal 2023-24 as compared to the previous y......
View Details
Source : Pharmabiz
Foreign Direct Investment
FDI
first quarter
June quarter
foreign equity infusion
software & hardware
greenfield projects
FIPB
DoP
Related News
- Morepen Laboratories to hive off medical devices business (15-01-2025)
- 'Expired' IV fluid issue: probe panel Initial report indicates 'human error' (15-01-2025)
- Odisha government to establish pharmaceutical hub in state (15-01-2025)
- WB bans use of medicines linked to Karnataka maternal deaths (15-01-2025)
- Strengthening antimicrobial resistance national action plans through evidence (15-01-2025)
- DGFT notifies updated export policy aligned with Finance Act 2024 to boost pharma trade efficiency (15-01-2025)
- Medical store owner arrested for selling addictive medicines (15-01-2025)
- Time Medical International Ventures (India) gets license from CDSCO to make MRI machines (14-01-2025)
- Scientists Discover New Molecule That Boosts Fat Metabolism Naturally (14-01-2025)
- Controversial saline: Questions raised on the quality of West Bengal Pharmaceutical firm (14-01-2025)